Skip to main content

Table 1 The demographic information for patients

From: Safety and feasibility study of ex vivo expanded allogeneic-NK cells infusion in patients with acute pneumonia caused by COVID-19

No

Code

Grouping

Gender

Age

Weight

Hospitalization

Statusa

1

NK-C-01

Control

Female

61

76

7

D

2

NK-C-02

Control

Male

53

89

15

D

3

NK-C-03

Control

Male

66

70

10

D

4

NK-C-04

Control

Female

51

75

8

D

5

NK-C-05

Control

Male

87

80

12

E

6

NK-T-01

Intervention-D1

Male

65

65

12

D

7

NK-T-02

Intervention-D1

Female

64

85

12

D

8

NK-T-03

Intervention-D1

Male

59

99

6

D

9

NK-T-04

Intervention-D2

Female

78

65

2

D

10

NK-T-05

Intervention-D2

Female

80

75

5

E

  1. aE expired, D discharged